Respiratory Syncytial Virus: Vaccination
Commons · Question 15055 · Tabled 19 Nov 2024 · Department of Health and Social Care · Official record
Answered 25 Nov 2024
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, when he plans to publish real world evidence on the effectiveness of the respiratory syncytial virus vaccine in the 75-80 cohort; how much such evidence has been collected; and whether such evidenc
Answer
Answered by Andrew Gwynne, 25 Nov 2024
The UK Health Security Agency is working on vaccine effectiveness analysis within the 75 to 80-year-old age group for this winter season 2024 to 2025. We are collating data on respitatory syncytial virus (RSV) hospitalisations in England and general pract...